J. Pawlotsky, New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges, Gastroenterology, vol.146, issue.5
DOI : 10.1053/j.gastro.2014.03.003

D. Smith, J. Bukh, C. Kuiken, A. Muerhoff, C. Rice et al., Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment Web resource. Hepatol Baltim Md, Avis%20expert%20Traitement%20janvier%202015+.pdf 6, pp.318-345, 2014.

O. Kalinina, H. Norder, S. Mukomolov, and L. Magnius, A Natural Intergenotypic Recombinant of Hepatitis C Virus Identified in St. Petersburg, Journal of Virology, vol.76, issue.8, pp.4034-4077, 2002.
DOI : 10.1128/JVI.76.8.4034-4043.2002

V. Morel, C. Fournier, C. François, E. Brochot, F. Helle et al., Genetic recombination of the hepatitis C virus: clinical implications, Journal of Viral Hepatitis, vol.133, issue.5, pp.77-83, 2011.
DOI : 10.1111/j.1365-2893.2010.01367.x

C. Hedskog, B. Doehle, K. Chodavarapu, V. Gontcharova, C. Garcia et al., Characterization of hepatitis C virus intergenotypic recombinant strains and associated virological response to sofosbuvir/ribavirin. Hepatol Baltim Md, Feb, vol.61, issue.2, pp.471-80, 2015.

P. Simmonds, J. Bukh, C. Combet, G. Deléage, N. Enomoto et al., Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatol Baltim Md, pp.962-73, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00313678

C. Ramiere, P. Tremeaux, A. Caporossi, M. Trabaud, F. Lebosse et al., Recent evidence of underestimated circulation of hepatitis C virus intergenotypic recombinant strain RF2k/1b in the Rhone-Alpes region, France: implications for antiviral treatment, Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull, vol.19, issue.43, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01244712

S. Larrat, J. Poveda, C. Coudret, K. Fusillier, N. Magnat et al., Sequencing Assays for Failed Genotyping with the Versant Hepatitis C Virus Genotype Assay (LiPA), Version 2.0, Journal of Clinical Microbiology, vol.51, issue.9, pp.2815-2836, 2013.
DOI : 10.1128/JCM.00586-13

A. Avó, I. Agua-doce, A. Andrade, and E. Pádua, Hepatitis C virus subtyping based on sequencing of the C/E1 and NS5B genomic regions in comparison to a commercially available line probe assay, Journal of Medical Virology, vol.20, issue.5, pp.815-837, 2013.
DOI : 10.1002/jmv.23545

M. Sulkowski, J. Eron, D. Wyles, R. Trinh, J. Lalezari et al., Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1, JAMA, vol.313, issue.12, pp.1223-1254, 2015.
DOI : 10.1001/jama.2015.1328

B. Jacka, F. Lamoury, P. Simmonds, G. Dore, J. Grebely et al., Sequencing of the Hepatitis C Virus: A Systematic Review Available from: http://www.ncbi.nlm.nih.gov/pmc/articles Genetic Heterogeneity of Hepatitis C Virus in Association with Antiviral Therapy Determined by Ultra-Deep Sequencing Available from, PLoS ONE PLoS ONE [Internet] Lauck M J Virol, vol.8686, issue.177, pp.3952-60, 2011.

R. Newman, T. Kuntzen, B. Weiner, A. Berical, P. Charlebois et al., Whole Genome Pyrosequencing of Rare Hepatitis C Virus Genotypes Enhances Subtype Classification and Identification of Naturally Occurring Drug Resistance Variants, Journal of Infectious Diseases, vol.208, issue.1, pp.17-31
DOI : 10.1093/infdis/jis679

M. Ninomiya, Y. Ueno, R. Funayama, T. Nagashima, Y. Nishida et al., Use of Illumina Deep Sequencing Technology To Differentiate Hepatitis C Virus Variants, Journal of Clinical Microbiology, vol.50, issue.3, 2012.
DOI : 10.1128/JCM.05715-11

L. Cuypers, J. Snoeck, B. Vrancken, L. Kerremans, G. Vuagniaux et al., A near-full length genotypic assay for HCV1b, Journal of Virological Methods, vol.209, pp.126-161, 2014.
DOI : 10.1016/j.jviromet.2014.09.009

X. Yang, P. Charlebois, S. Gnerre, M. Coole, N. Lennon et al., De novo assembly of highly diverse viral populations, BMC Genomics, vol.13, issue.1, p.475, 2012.
DOI : 10.1084/jem.20090378

S. Kuraku, C. Zmasek, O. Nishimura, and K. Katoh, aLeaves facilitates on-demand exploration of metazoan gene family trees on MAFFT sequence alignment server with enhanced interactivity, Nucleic Acids Research, vol.41, issue.W1, pp.22-30, 2013.
DOI : 10.1093/nar/gkt389

M. Han and C. Zmasek, phyloXML: XML for evolutionary biology and comparative genomics, BMC Bioinformatics, vol.10, issue.1
DOI : 10.1186/1471-2105-10-356

F. Corpet, Multiple sequence alignment with hierarchical clustering, Nucleic Acids Research, vol.16, issue.22, 1988.
DOI : 10.1093/nar/16.22.10881

|. Pymol, Available from: https, pymol.org [Internet]

T. Appleby, J. Perry, E. Murakami, O. Barauskas, J. Feng et al., Viral replication. Structural basis for RNA replication by the hepatitis C virus polymerase, Science. Feb, vol.13347, issue.6223, pp.771-776, 2015.

E. Donaldson, P. Harrington, O. Rear, J. Naeger, and L. , Clinical evidence and bioinformatics characterization of potential hepatitis C virus resistance pathways for sofosbuvir. Hepatol Baltim Md, pp.56-65, 2015.

W. Kati, G. Koev, M. Irvin, J. Beyer, Y. Liu et al., Activity and Resistance Profile of Dasabuvir, a Nonnucleoside Hepatitis C Virus Polymerase Inhibitor, Antimicrobial Agents and Chemotherapy, vol.59, issue.3, pp.1505-1516, 2014.
DOI : 10.1128/AAC.04619-14

G. Internet and ]. , Available from: http://hcv

E. Gane, C. Stedman, R. Hyland, X. Ding, E. Svarovskaia et al., Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C, New England Journal of Medicine, vol.368, issue.1, pp.34-44, 2013.
DOI : 10.1056/NEJMoa1208953

J. Lalezari, D. Nelson, R. Hyland, M. Lin, S. Rossi et al., Once-Daily Sofosbuvir Plus Ribavirin Given for 12 or 24 Weeks in Treatment-Naïve Patients With HCV Infection: the QUANTUM Study Update on hepatitis C virus resistance to direct-acting antiviral agents, J Hepatol Antiviral Res, vol.56108, pp.181-91, 2013.

E. Svarovskaia, R. Martin, J. Mchutchison, M. Miller, and H. Mo, Abundant Drug-Resistant NS3 Mutants Detected by Deep Sequencing in Hepatitis C Virus-Infected Patients Undergoing NS3 Protease Inhibitor Monotherapy, Journal of Clinical Microbiology, vol.50, issue.10, pp.3267-74, 2012.
DOI : 10.1128/JCM.00838-12

S. Nakamoto, T. Kanda, S. Wu, H. Shirasawa, and O. Yokosuka, Hepatitis C virus NS5A inhibitors and drug resistance mutations, World Journal of Gastroenterology, vol.20, issue.11, pp.2902-2914, 2014.
DOI : 10.3748/wjg.v20.i11.2902

E. Svarovskaia, H. Dvory-sobol, N. Parkin, C. Hebner, V. Gontcharova et al., Infrequent Development of Resistance in Genotype 1-6 Hepatitis C Virus-Infected Subjects Treated With Sofosbuvir in Phase 2 and 3 Clinical Trials, Clinical Infectious Diseases, vol.59, issue.12, pp.1666-74, 2014.
DOI : 10.1093/cid/ciu697

J. Mellor, E. Holmes, L. Jarvis, P. Yap, and P. Simmonds, Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification, Journal of General Virology, vol.76, issue.10, pp.2493-507, 1995.
DOI : 10.1099/0022-1317-76-10-2493

B. Besse, M. Coste-burel, N. Bourgeois, C. Feray, B. Imbert-marcille et al., Genotyping and resistance profile of hepatitis C (HCV) genotypes 1???6 by sequencing the NS3 protease region using a single optimized sensitive method, Journal of Virological Methods, vol.185, issue.1, pp.94-100, 2012.
DOI : 10.1016/j.jviromet.2012.06.011

K. Sandres-sauné, P. Deny, C. Pasquier, V. Thibaut, G. Duverlie et al., Determining hepatitis C genotype by analyzing the sequence of the NS5b region, Journal of Virological Methods, vol.109, issue.2, pp.187-93, 2003.
DOI : 10.1016/S0166-0934(03)00070-3

R. Tellier, J. Bukh, S. Emerson, R. Miller, and R. Purcell, Long PCR and its application to hepatitis viruses: amplification of hepatitis A, hepatitis B, and hepatitis C virus genomes, J Clin Microbiol, vol.34, issue.12, pp.3085-91, 1996.

S. Nakatani, C. Santos, I. Riediger, M. Krieger, C. Duarte et al., Development of Hepatitis C Virus Genotyping by Real-Time PCR Based on the NS5B Region, PLoS ONE, vol.5, issue.4, 2010.
DOI : 10.1371/journal.pone.0010150.t002

E. Zhang, D. Bartels, J. Frantz, S. Seepersaud, J. Lippke et al., Development of a sensitive RT-PCR method for amplifying and sequencing near full-length HCV genotype 1 RNA from patient samples, Virology Journal, vol.10, issue.1, pp.53-56, 2013.
DOI : 10.1371/journal.pone.0034372

O. Hépatite, C. Internet, ]. Who, C. Hedskog, B. Doehle et al., Available from: http://www.who.int/mediacentre Characterization of hepatitis C virus intergenotypic recombinant strains and associated virological response to sofosbuvir/ribavirin. Hepatol Baltim Md, Feb, vol.61, issue.2, pp.471-80, 2014.

C. Ramiere, P. Tremeaux, A. Caporossi, M. Trabaud, F. Lebosse et al., Recent evidence of underestimated circulation of hepatitis C virus intergenotypic recombinant strain RF2k/1b in the Rhone-Alpes region, France: implications for antiviral treatment, Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull, vol.19, issue.43, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01244712

D. Smith, J. Bukh, C. Kuiken, A. Muerhoff, C. Rice et al., Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment Web resource. Hepatol Baltim Md, pp.318-345, 2014.

P. Friebe and R. Bartenschlager, Genetic Analysis of Sequences in the 3' Nontranslated Region of Hepatitis C Virus That Are Important for RNA Replication, Journal of Virology, vol.76, issue.11, pp.5326-5364, 2002.
DOI : 10.1128/JVI.76.11.5326-5338.2002

K. Moriishi and Y. Matsuura, Exploitation of Lipid Components by Viral and Host Proteins for Hepatitis C Virus Infection. Front Microbiol, Feb, vol.143, 2012.

J. Cuevas, F. Gonzalez-candelas, A. Moya, and R. Sanjuan, Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In Vivo, Journal of Virology, vol.83, issue.11, pp.5760-5764, 2009.
DOI : 10.1128/JVI.00201-09

N. Marascio, C. Torti, M. Liberto, and A. Focà, Update on different aspects of HCV variability: focus on NS5B polymerase, BMC Infectious Diseases, vol.14, issue.Suppl 5, p.1, 2014.
DOI : 10.1111/j.1365-2893.2010.01342.x

G. Wang, S. Sherrill-mix, K. Chang, C. Quince, and F. Bushman, Hepatitis C Virus Transmission Bottlenecks Analyzed by Deep Sequencing, Journal of Virology, vol.84, issue.12, pp.6218-6246, 2010.
DOI : 10.1128/JVI.02271-09

R. Bull, F. Luciani, K. Mcelroy, S. Gaudieri, S. Pham et al., Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection. PLoS Pathog Hepatitis C virus molecular evolution: Transmission, disease progression and antiviral therapy, World J Gastroenterol WJG, vol.720, issue.943, pp.1002243-1215992, 2011.

P. Qiu, X. Cai, L. Wang, J. Greene, M. B. Kalinina et al., Hepatitis C virus whole genome position weight matrix and robust primer design, BMC Microbiol A Natural Intergenotypic Recombinant of Hepatitis C Virus Identified in St. Petersburg. J Virol, vol.276, issue.8, pp.29-144034, 2002.

A. Galli and J. Bukh, Comparative analysis of the molecular mechanisms of recombination in hepatitis C virus, Trends in Microbiology, vol.22, issue.6, pp.354-64
DOI : 10.1016/j.tim.2014.02.005

V. Morel, C. Fournier, C. François, E. Brochot, F. Helle et al., Genetic recombination of the hepatitis C virus: clinical implications, Journal of Viral Hepatitis, vol.133, issue.5, pp.77-83, 2011.
DOI : 10.1111/j.1365-2893.2010.01367.x

F. Gonzalez-candelas, F. Lopez-labrador, and M. Bracho, Recombination in Hepatitis C Virus. Viruses, pp.2006-2030, 2011.

V. Sentandreu, N. Jiménez-hernández, M. Torres-puente, M. Bracho, A. Valero et al., Evidence of Recombination in Intrapatient Populations of Hepatitis C Virus, PLoS ONE, vol.269, issue.11, p.3239, 2008.
DOI : 10.1371/journal.pone.0003239.s004

P. Jackowiak, K. Kuls, L. Budzko, A. Mania, M. Figlerowicz et al., Phylogeny and molecular evolution of the hepatitis C virus, Infection, Genetics and Evolution, vol.21, pp.67-82, 2014.
DOI : 10.1016/j.meegid.2013.10.021

R. Ross, J. Verbeeck, S. Viazov, P. Lemey, M. Van-ranst et al., Evidence for a Complex Mosaic Genome Pattern in a Full-length Hepatitis C Virus Sequence, Evol Bioinforma Online, vol.4, pp.249-54, 2008.

V. Morel, V. Descamps, C. François, C. Fournier, E. Brochot et al., Emergence of a genomic variant of the recombinant 2k/1b strain during a mixed Hepatitis C infection: A case report, Journal of Clinical Virology, vol.47, issue.4, pp.382-388, 2010.
DOI : 10.1016/j.jcv.2010.01.011

J. Messina, I. Humphreys, A. Flaxman, A. Brown, G. Cooke et al., Global distribution and prevalence of hepatitis C virus genotypes. Hepatol Baltim Md Use of Sequence Analysis of the NS5B Region for Routine Genotyping of Hepatitis C Virus with Reference to C/E1 and 5? Untranslated Region Sequences, J Clin Microbiol, vol.2345, issue.4, pp.1102-1114, 2007.

S. Larrat, J. Poveda, C. Coudret, K. Fusillier, N. Magnat et al., Sequencing Assays for Failed Genotyping with the Versant Hepatitis C Virus Genotype Assay (LiPA), Version 2.0, Journal of Clinical Microbiology, vol.51, issue.9, pp.2815-2836, 2013.
DOI : 10.1128/JCM.00586-13

P. Simmonds, J. Bukh, C. Combet, G. Deléage, N. Enomoto et al., Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatol Baltim Md, pp.962-73, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00313678

J. Mellor, E. Holmes, L. Jarvis, P. Yap, and P. Simmonds, Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification, Journal of General Virology, vol.76, issue.10, pp.2493-507, 1995.
DOI : 10.1099/0022-1317-76-10-2493

D. Pham, P. Leuangwutiwong, A. Jittmittraphap, N. Luplertlop, H. Bach et al., High prevalence of Hepatitis C virus genotype 6 in Vietnam, Asian Pac J Allergy Immunol Launched Allergy Immunol Soc Thail, vol.27, pp.2-3153, 2009.

K. Sandres-sauné, P. Deny, C. Pasquier, V. Thibaut, G. Duverlie et al., Determining hepatitis C genotype by analyzing the sequence of the NS5b region, Journal of Virological Methods, vol.109, issue.2, pp.187-93, 2003.
DOI : 10.1016/S0166-0934(03)00070-3

S. Nakatani, C. Santos, I. Riediger, M. Krieger, C. Duarte et al., Development of Hepatitis C Virus Genotyping by Real-Time PCR Based on the NS5B Region, PLoS ONE, vol.5, issue.4, 2010.
DOI : 10.1371/journal.pone.0010150.t002

F. Sanger, S. Nicklen, and A. Coulson, DNA sequencing with chain-terminating inhibitors, Proceedings of the National Academy of Sciences, vol.74, issue.12, pp.5463-5470, 1977.
DOI : 10.1073/pnas.74.12.5463

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC431765

R. Available-from-ross, S. Viazov, B. Wolters, and M. Roggendorf, Towards a better resolution of hepatitis C virus variants: CLIP??? sequencing of an HCV core fragment and automated assignment of genotypes and subtypes, Journal of Virological Methods, vol.148, issue.1-2, pp.25-33, 2008.
DOI : 10.1016/j.jviromet.2007.10.012

Y. Casanova, T. Boeira, R. Da, E. Sisti, Á. Celmer et al., A complete molecular biology assay for hepatitis C virus detection, quantification and genotyping. Rev Soc Bras Med Trop, pp.287-94, 2014.

A. Avó, I. Agua-doce, A. Andrade, and E. Pádua, Hepatitis C virus subtyping based on sequencing of the C/E1 and NS5B genomic regions in comparison to a commercially available line probe assay, Journal of Medical Virology, vol.20, issue.5, pp.815-837, 2013.
DOI : 10.1002/jmv.23545

R. Yang, X. Cong, S. Du, R. Fei, H. Rao et al., Performance Comparison of the Versant HCV Genotype 2.0 Assay (LiPA) and the Abbott Realtime HCV Genotype II Assay for Detecting Hepatitis C Virus Genotype 6, Journal of Clinical Microbiology, vol.52, issue.10, pp.3685-92, 2014.
DOI : 10.1128/JCM.00882-14

J. Verbeeck, M. Stanley, J. Shieh, L. Celis, E. Huyck et al., Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0, Journal of Clinical Microbiology, vol.46, issue.6, pp.1901-1907, 2008.
DOI : 10.1128/JCM.02390-07

E. Sablon and F. Shapiro, Advances in Molecular Diagnosis of HBV Infection and Drug Resistance, International Journal of Medical Sciences
DOI : 10.7150/ijms.2.8

C. Duarte, L. Foti, S. Nakatani, I. Riediger, C. Poersch et al., A Novel Hepatitis C Virus Genotyping Method Based on Liquid Microarray, PLoS ONE, vol.8, issue.5, 2010.
DOI : 10.1371/journal.pone.0012822.s001

J. Park, J. Kim, O. Kwon, K. Lee, Y. Chai et al., Development and clinical evaluation of a microarray for hepatitis C virus genotyping, Journal of Virological Methods, vol.163, issue.2, pp.269-75, 2010.
DOI : 10.1016/j.jviromet.2009.10.008

D. Gryadunov, F. Nicot, M. Dubois, V. Mikhailovich, A. Zasedatelev et al., Hepatitis C Virus Genotyping Using an Oligonucleotide Microarray Based on the NS5B Sequence, Journal of Clinical Microbiology, vol.48, issue.11, 2010.
DOI : 10.1128/JCM.01265-10

F. Poordad, J. Mccone, B. Bacon, S. Bruno, M. Manns et al., Boceprevir for Untreated Chronic HCV Genotype 1 Infection, New England Journal of Medicine, vol.364, issue.13, pp.1195-206, 2011.
DOI : 10.1056/NEJMoa1010494

URL : https://hal.archives-ouvertes.fr/hal-00867494

E. Poveda, D. Wyles, Á. Mena, J. Pedreira, Á. Castro-iglesias et al., Update on hepatitis C virus resistance to direct-acting antiviral agents, Antiviral Research, vol.108, pp.181-91, 2014.
DOI : 10.1016/j.antiviral.2014.05.015

M. Gao, Antiviral activity and resistance of HCV NS5A replication complex inhibitors, Current Opinion in Virology, vol.3, issue.5, pp.514-534, 2013.
DOI : 10.1016/j.coviro.2013.06.014

S. Nakamoto, T. Kanda, S. Wu, H. Shirasawa, and O. Yokosuka, Hepatitis C virus NS5A inhibitors and drug resistance mutations, World Journal of Gastroenterology, vol.20, issue.11, pp.2902-2914, 2014.
DOI : 10.3748/wjg.v20.i11.2902

M. Bourlière, V. Oules, C. Ansaldi, X. Adhoute, and P. Castellani, Sofosbuvir as backbone of interferon free treatments. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver, pp.212-232, 2014.

H. Yee, M. Chang, C. Pocha, J. Lim, D. Ross et al., Update on the Management and Treatment of Hepatitis C Virus Infection: Recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office, The American Journal of Gastroenterology, vol.52, issue.5, pp.669-89, 2012.
DOI : 10.1016/S0168-8278(11)61358-5

E. Donaldson, P. Harrington, O. Rear, J. Naeger, and L. , Clinical evidence and bioinformatics characterization of potential hepatitis C virus resistance pathways for sofosbuvir. Hepatol Baltim Md, pp.56-65, 2015.

W. Kati, G. Koev, M. Irvin, J. Beyer, Y. Liu et al., Activity and Resistance Profile of Dasabuvir, a Nonnucleoside Hepatitis C Virus Polymerase Inhibitor, Antimicrobial Agents and Chemotherapy, vol.59, issue.3, pp.1505-1516, 2014.
DOI : 10.1128/AAC.04619-14

M. Götte, Resistance to nucleotide analogue inhibitors of hepatitis C virus NS5B: mechanisms and clinical relevance, Current Opinion in Virology, vol.8, pp.104-112
DOI : 10.1016/j.coviro.2014.07.010

B. Jacka, F. Lamoury, P. Simmonds, G. Dore, J. Grebely et al., Sequencing of the Hepatitis C Virus: A Systematic Review, PLoS ONE, vol.26, issue.6, 2013.
DOI : 10.1371/journal.pone.0067073.s003

C. Li, L. Lu, X. Zhang, and D. Murphy, Entire genome sequences of two new HCV subtypes, 6r and 6s, and characterization of unique HVR1 variation patterns within genotype 6, Journal of Viral Hepatitis, vol.100, issue.Suppl., 2009.
DOI : 10.1111/j.1365-2893.2009.01086.x

C. Li, Y. Fu, L. Lu, J. W. Yu, J. Hagedorn et al., Complete genomic sequences for hepatitis C virus subtypes 6e and 6g isolated from Chinese patients with injection drug use and HIV-1 co-infection, Journal of Medical Virology, vol.78, issue.8, pp.1061-1070, 2006.
DOI : 10.1002/jmv.20663

L. Lu, C. Li, Y. Xu, and D. Murphy, Full-length genomes of 16 hepatitis C virus genotype 1 isolates representing subtypes 1c, 1d, 1e, 1g, 1h, 1i, 1j and 1k, and two new subtypes 1m and 1n, and four unclassified variants reveal ancestral relationships among subtypes, Journal of General Virology, vol.95, issue.Pt_7, pp.1479-87, 2014.
DOI : 10.1099/vir.0.064980-0

M. Gededzha, S. Selabe, J. Blackard, T. Kyaw, and M. Mphahlele, Near full-length genome analysis of HCV genotype 5 strains from South Africa, Infection, Genetics and Evolution, vol.21, pp.118-141, 2014.
DOI : 10.1016/j.meegid.2013.10.022

T. Kuntzen, J. Timm, A. Berical, L. Lewis-ximenez, A. Jones et al., Viral Sequence Evolution in Acute Hepatitis C Virus Infection, Journal of Virology, vol.81, issue.21, pp.11658-68, 2007.
DOI : 10.1128/JVI.00995-07

E. Yao, J. Tavis, L. Cuypers, J. Snoeck, B. Vrancken et al., A general method for nested RT-PCR amplification and sequencing the complete HCV genotype 1 open reading frame A near-full length genotypic assay for HCV1b, Virol J. J Virol Methods, vol.2209, issue.60, pp.88126-88161, 2005.

M. Lauck, M. Alvarado-mora, E. Becker, D. Bhattacharya, R. Striker et al., Analysis of Hepatitis C Virus Intrahost Diversity across the Coding Region by Ultradeep Pyrosequencing, Journal of Virology, vol.86, issue.7, pp.3952-60
DOI : 10.1128/JVI.06627-11

A. Nasu, H. Marusawa, Y. Ueda, N. Nishijima, K. Takahashi et al., Genetic Heterogeneity of Hepatitis C Virus in Association with Antiviral Therapy Determined by Ultra-Deep Sequencing, PLoS ONE, vol.272, issue.9, 2011.
DOI : 10.1371/journal.pone.0024907.s004

S. Ohtsuru, Y. Ueda, H. Marusawa, T. Inuzuka, N. Nishijima et al., Dynamics of Defective Hepatitis C Virus Clones in Reinfected Liver Grafts in Liver Transplant Recipients: Ultradeep Sequencing Analysis, Journal of Clinical Microbiology, vol.51, issue.11, pp.3645-52, 2013.
DOI : 10.1128/JCM.00676-13

T. Kuntzen, A. Berical, J. Ndjomou, P. Bennett, A. Schneidewind et al., A set of reference sequences for the hepatitis C genotypes 4d, 4f, and 4k covering the full open reading frame, Journal of Medical Virology, vol.183, issue.8, p.1370, 2008.
DOI : 10.1002/jmv.21240

H. Jia, Y. Guo, W. Zhao, and K. Wang, Long-range PCR in next-generation sequencing: comparison of six enzymes and evaluation on the MiSeq sequencer, Scientific Reports, vol.18, 2014.
DOI : 10.1038/srep05737

N. Kato, K. Abe, K. Mori, Y. Ariumi, H. Dansako et al., Genetic variability and diversity of intracellular genome-length hepatitis C virus RNA in long-term cell culture, Archives of Virology, vol.92, issue.1, pp.77-85, 2009.
DOI : 10.1007/s00705-008-0282-8

A. Tuplin, J. Wood, D. Evans, A. Patel, and P. Simmonds, Thermodynamic and phylogenetic prediction of RNA secondary structures in the coding region of hepatitis C virus, RNA, vol.8, issue.6, 2002.
DOI : 10.1017/S1355838202554066

X. Fan, Y. Xu, D. Bisceglie, and A. , Efficient amplification and cloning of near full-length hepatitis C virus genome from clinical samples, Biochemical and Biophysical Research Communications, vol.346, issue.4, pp.1163-72, 2006.
DOI : 10.1016/j.bbrc.2006.06.039

R. Tellier, J. Bukh, S. Emerson, R. Miller, and R. Purcell, Long PCR and its application to hepatitis viruses: amplification of hepatitis A, hepatitis B, and hepatitis C virus genomes, J Clin Microbiol, 1996.

M. Yanagi, R. Purcell, S. Emerson, and J. Bukh, Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee, Proceedings of the National Academy of Sciences, vol.94, issue.16, pp.8738-8781, 1997.
DOI : 10.1073/pnas.94.16.8738

D. Zhou, X. Fan, D. Tan, Y. Xu, J. Tavis et al., Separation of near full-length hepatitis C virus quasispecies variants from a complex population, Journal of Virological Methods, vol.141, issue.2, pp.220-224, 2007.
DOI : 10.1016/j.jviromet.2006.12.002

Z. Xu, X. Fan, Y. Xu, D. Bisceglie, and A. , Comparative Analysis of Nearly Full-Length Hepatitis C Virus Quasispecies from Patients Experiencing Viral Breakthrough during Antiviral Therapy: Clustered Mutations in Three Functional Genes, E2, NS2, and NS5a, Journal of Virology, vol.82, issue.19, pp.9417-9441, 2008.
DOI : 10.1128/JVI.00896-08

E. Zhang, D. Bartels, J. Frantz, S. Seepersaud, J. Lippke et al., Development of a sensitive RT-PCR method for amplifying and sequencing near full-length HCV genotype 1 RNA from patient samples A strategy for obtaining near full-length HCV cDNA clones (assemblicons) by assembly PCR, Virol J. 2013 Feb J Virol Methods Feb, vol.1210123, issue.2, pp.115-139, 2005.

A. Maxam and W. Gilbert, A new method for sequencing DNA., Proceedings of the National Academy of Sciences, vol.74, issue.2, pp.99-103, 1977.
DOI : 10.1073/pnas.74.2.560

E. Mardis, Next-Generation DNA Sequencing Methods, Annual Review of Genomics and Human Genetics, vol.9, issue.1, pp.387-402, 2008.
DOI : 10.1146/annurev.genom.9.081307.164359

J. Rothberg, W. Hinz, T. Rearick, J. Schultz, W. Mileski et al., An integrated semiconductor device enabling non-optical genome sequencing, Nature, vol.32, issue.7, pp.348-52, 2011.
DOI : 10.1038/nature10242

E. Mardis, Next-Generation Sequencing Platforms, Annual Review of Analytical Chemistry, vol.6, issue.1, pp.287-303, 2013.
DOI : 10.1146/annurev-anchem-062012-092628

M. Metzker, Sequencing technologies ??? the next generation, Nature Reviews Genetics, vol.37, issue.1, 2010.
DOI : 10.1038/nrg2626

D. Munroe and T. Harris, Third-generation sequencing fireworks at Marco Island, Nature Biotechnology, vol.4, issue.5, pp.426-434, 2010.
DOI : 10.1038/nbt0510-426

J. Thompson and P. Milos, The properties and applications of single-molecule DNA sequencing

E. Schadt, S. Turner, and A. Kasarskis, A window into third-generation sequencing, Genome Biol. Hum Mol Genet, vol.1219, issue.2R2, pp.217-82, 2010.

Y. Wang, Q. Yang, and Z. Wang, The evolution of nanopore sequencing. Front Genet, 2005.

S. Kumar, C. Tao, M. Chien, B. Hellner, A. Balijepalli et al., PEG-Labeled Nucleotides and Nanopore Detection for Single Molecule DNA Sequencing by Synthesis. Sci Rep, p.111, 2012.

N. Sequencing, -. Loman, N. Misra, R. Dallman, T. Constantinidou et al., Available from: http://www2.technologyreview.com/article/427677/nanopore-sequencing/ 86 Performance comparison of benchtop high-throughput sequencing platforms, Nat Biotechnol, 2012.

S. Jünemann, F. Sedlazeck, K. Prior, A. Albersmeier, U. John et al., Updating benchtop sequencing performance comparison, Nature Biotechnology, vol.9, issue.4, pp.294-300
DOI : 10.1186/1471-2164-13-341

P. Halfon and S. Locarnini, Hepatitis C virus resistance to protease inhibitors, Journal of Hepatology, vol.55, issue.1, pp.192-206, 2011.
DOI : 10.1016/j.jhep.2011.01.011

URL : https://hal.archives-ouvertes.fr/hal-01392316

P. Halfon and C. Sarrazin, Future treatment of chronic hepatitis C with direct acting antivirals: is resistance important? Liver Int Off J Int Assoc Study Liver. 2012 Feb, pp.79-87

M. Prosperi, L. Yin, D. Nolan, A. Lowe, M. Goodenow et al., Empirical validation of viral quasispecies assembly algorithms: state-of-the-art and challenges, Scientific Reports, vol.172, issue.6, 2013.
DOI : 10.1038/srep02837

K. Mcelroy, T. Thomas, F. Luciani, H. Auger, Y. Jaszczyszyn et al., Deep sequencing of evolving pathogen populations: applications, errors, and bioinformatic solutions. Microb Inform Exp Ten years of next-generation sequencing technology, Trends Genet TIG, vol.430, issue.9, pp.418-444, 2014.

H. Buermans and J. Den-dunnen, Next generation sequencing technology: Advances and applications, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1842, issue.10, pp.1932-1973, 1842.
DOI : 10.1016/j.bbadis.2014.06.015

B. Palmer, Z. Dimitrova, P. Skums, O. Crosbie, E. Kenny-walsh et al., Analysis of the Evolution and Structure of a Complex Intrahost Viral Population in Chronic Hepatitis C Virus Mapped by Ultradeep Pyrosequencing, Journal of Virology, vol.88, issue.23, pp.13709-13730, 2014.
DOI : 10.1128/JVI.01732-14

M. Miura, S. Maekawa, S. Takano, N. Komatsu, A. Tatsumi et al., Deep-Sequencing Analysis of the Association between the Quasispecies Nature of the Hepatitis C Virus Core Region and Disease Progression, Journal of Virology, vol.87, issue.23, pp.12541-51, 2013.
DOI : 10.1128/JVI.00826-13

V. Montoya, A. Olmstead, N. Janjua, P. Tang, J. Grebely et al., Differentiation of acute from chronic hepatitis C virus infection by NS5B deep sequencing: A population-level tool for incidence estimation Contribution of a mutational bias in hepatitis C virus replication to the genetic barrier in the development of drug resistance, Hepatology. Proc Natl Acad Sci, vol.97108, issue.51, pp.20509-20522, 2011.

M. Ripoli and V. Pazienza, Impact of HCV genetic differences on pathobiology of disease, Expert Review of Anti-infective Therapy, vol.9, issue.9, pp.747-59, 2011.
DOI : 10.1586/eri.11.94

J. Quer, J. Gregori, F. Rodríguez-frias, M. Buti, A. Madejon et al., High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current Methods, Journal of Clinical Microbiology, vol.53, issue.1, pp.219-245
DOI : 10.1128/JCM.02093-14

B. Bartolini, E. Giombini, P. Zaccaro, M. Selleri, G. Rozera et al., Extent of HCV NS3 protease variability and resistance-associated mutations assessed by next generation sequencing in HCV monoinfected and HIV/HCV coinfected patients, Virus Research, vol.177, issue.2, pp.205-213, 2013.
DOI : 10.1016/j.virusres.2013.08.001

M. Kirst, E. Li, C. Wang, H. Dong, C. Liu et al., Deep Sequencing Analysis of HCV NS3 Resistance-Associated Variants and Mutation Linkage in Liver Transplant Recipients, PLoS ONE, vol.15, issue.1, 2013.
DOI : 10.1371/journal.pone.0069698.s001

S. Margeridon-thermet, L. Pogam, S. Li, L. Liu, T. Shulman et al., Similar Prevalence of Low-Abundance Drug-Resistant Variants in Treatment-Naive Patients with Genotype 1a and 1b Hepatitis C Virus Infections as Determined by Ultradeep Pyrosequencing, PLoS ONE, vol.55, issue.8, 2014.
DOI : 10.1371/journal.pone.0105569.s001

I. Jacobson, G. Dore, G. Foster, M. Fried, M. Radu et al., Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial, The Lancet, vol.384, issue.9941, pp.403-416, 2014.
DOI : 10.1016/S0140-6736(14)60494-3

N. Akuta, F. Suzuki, T. Fukushima, Y. Kawamura, H. Sezaki et al., Prediction of Treatment Efficacy and Telaprevir-Resistant Variants after Triple Therapy in Patients Infected with Hepatitis C Virus Genotype 1, Journal of Clinical Microbiology, vol.51, issue.9, pp.2862-2870, 2013.
DOI : 10.1128/JCM.01129-13

N. Akuta, F. Suzuki, T. Fukushima, Y. Kawamura, H. Sezaki et al., Utility of Detection of Telaprevir-Resistant Variants for Prediction of Efficacy of Treatment of Hepatitis C Virus Genotype 1 Infection, Journal of Clinical Microbiology, vol.52, issue.1, pp.193-200, 2014.
DOI : 10.1128/JCM.02371-13

S. Larrat, O. Kulkarni, C. J. Beugnot, R. Blum, M. Fusillier et al., Ultradeep Pyrosequencing of NS3 To Predict Response to Triple Therapy with Protease Inhibitors in Previously Treated Chronic Hepatitis C Patients, Journal of Clinical Microbiology, vol.53, issue.2, pp.389-97, 2015.
DOI : 10.1128/JCM.02547-14

URL : https://hal.archives-ouvertes.fr/hal-01132344

T. Applegate, S. Gaudieri, A. Plauzolles, A. Chopra, J. Grebely et al., Naturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis C, Antiviral Therapy, vol.20, issue.2
DOI : 10.3851/IMP2821

J. Pawlotsky, New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges, Gastroenterology, vol.146, issue.5, p.1176, 2014.
DOI : 10.1053/j.gastro.2014.03.003

C. Sarrazin, H. Dvory-sobol, E. Svarovskaia, B. Doehle, J. Mccarville et al., Baseline and Postbaseline Resistance Analyses of Phase 2/3 Studies of Ledipasvir/Sofosbuvir ± RBV. AASLD Liver Meeting, 1926.

T. Tran, T. Morgan, P. Thuluvath, K. Etzkorn, F. Hinestrosa et al., Safety and Efficacy of Treatment with Sofosbuvir + GS-5816 ± Ribavirin for 8 or 12 Weeks in Treatment-Naïve Patients with Genotype 1-6 HCV Infection, AASLD Liver Meeting, 2014.

E. Svarovskaia, H. Dvory-sobol, N. Parkin, C. Hebner, V. Gontcharova et al., Infrequent Development of Resistance in Genotype 1-6 Hepatitis C Virus-Infected Subjects Treated With Sofosbuvir in Phase 2 and 3 Clinical Trials, Clinical Infectious Diseases, vol.59, issue.12, pp.1666-74, 2014.
DOI : 10.1093/cid/ciu697

H. Ji, R. Kozak, M. Biondi, R. Pilon, D. Vallee et al., Next generation sequencing of the hepatitis C virus NS5B gene reveals potential novel S282 drug resistance mutations, Virology, vol.477, 2015.
DOI : 10.1016/j.virol.2014.12.037

M. Ninomiya, Y. Ueno, R. Funayama, T. Nagashima, Y. Nishida et al., Use of Illumina Deep Sequencing Technology To Differentiate Hepatitis C Virus Variants, Journal of Clinical Microbiology, vol.50, issue.3, 2012.
DOI : 10.1128/JCM.05715-11

S. Fafi-kremer, I. Fofana, E. Soulier, P. Carolla, P. Meuleman et al., Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation, The Journal of Experimental Medicine, vol.119, issue.9, pp.2019-2050, 2010.
DOI : 10.1073/pnas.0503596102

E. Schvoerer, E. Soulier, C. Royer, A. Renaudin, C. Thumann et al., Early Evolution of Hepatitis C Virus (HCV) Quasispecies after Liver Transplant for HCV???Related Disease, The Journal of Infectious Diseases, vol.196, issue.4, pp.528-564, 2007.
DOI : 10.1086/519691

R. Newman, T. Kuntzen, B. Weiner, A. Berical, P. Charlebois et al., Whole Genome Pyrosequencing of Rare Hepatitis C Virus Genotypes Enhances Subtype Classification and Identification of Naturally Occurring Drug Resistance Variants, Journal of Infectious Diseases, vol.208, issue.1, pp.17-31
DOI : 10.1093/infdis/jis679

E. Gane, C. Stedman, R. Hyland, X. Ding, E. Svarovskaia et al., Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C, New England Journal of Medicine, vol.368, issue.1, pp.34-44, 2013.
DOI : 10.1056/NEJMoa1208953

J. Lalezari, D. Nelson, R. Hyland, M. Lin, S. Rossi et al., Once-Daily Sofosbuvir Plus Ribavirin Given for 12 or 24 Weeks in Treatment-Naïve Patients With HCV Infection: the QUANTUM Study, J Hepatol, vol.56, issue.1, pp.88-100, 2013.

J. Raghwani, X. Thomas, S. Koekkoek, J. Schinkel, R. Molenkamp et al., Origin and Evolution of the Unique Hepatitis C Virus Circulating Recombinant Form 2k/1b, Journal of Virology, vol.86, issue.4, 2012.
DOI : 10.1128/JVI.06184-11

S. Pham, R. Bull, J. Bennett, W. Rawlinson, G. Dore et al., Frequent multiple hepatitis C virus infections among injection drug users in a prison setting, Hepatology, vol.271, issue.Suppl. 5, 2010.
DOI : 10.1002/hep.23885

A. Mcnaughton, E. Thomson, K. Templeton, R. Gunson, and E. Leitch, Mixed Genotype Hepatitis C Infections and Implications for Treatment. Hepatol Baltim Md, p.1209, 2014.